Clinical Research Directory
Browse clinical research sites, groups, and studies.
Appropriateness of Angioplasty in Patients With Chronic Coronary Syndromes
Sponsor: University of Sao Paulo General Hospital
Summary
Percutaneous coronary intervention (PCI) has dramatically changed the treatment of obstructive coronary artery disease patients. PCI is indicated in patients with chronic coronary syndrome (CCS) symptoms unresponsive to optimized medical therapy. The American College of Cardiology Foundation and partners developed in 2009 - and updated them in May 2017 - the appropriateness criteria for PCI to support the rational use of PCI in chronic patients and to provide patients with high-quality cardiovascular care. Since then, these criteria have been applied to guide physicians and serve as metrics of the quality of care based on the best available scientific evidence. Countries like the United States and Japan already have robust studies on the topic with important repercussions on clinical practice. In Brazil, to date, there are no studies on the adequacy of PCIs in patients with CCS.
Official title: Appropriateness of Angioplasty in Patients With Chronic Coronary Syndromes in a Cardiology Reference Hospital - The RIGHT-PCI Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
1875
Start Date
2017-12-01
Completion Date
2025-12-31
Last Updated
2024-08-09
Healthy Volunteers
No
Conditions
Interventions
Percutaneous Coronary Intervention (PCI)
A percutaneous coronary intervention (PCI) is a minimally invasive procedure to open blocked coronary (heart) arteries. An older name for PCI is coronary angioplasty with stenting or angioplasty for short.
Locations (1)
Heart Institute (InCor-HCFMUSP)
São Paulo, São Paulo, Brazil